Browse > Article
http://dx.doi.org/10.15324/kjcls.2020.52.3.188

Risk of Stroke according to the Duration of Diabetes Mellitus with Hypertension  

Kim, Hee Sung (Department of Biomedical Laboratory Science, Catholic Kwandong University)
Publication Information
Korean Journal of Clinical Laboratory Science / v.52, no.3, 2020 , pp. 188-193 More about this Journal
Abstract
Stroke is a major cause of death and disorder, and diabetes mellitus (DM) is a significant risk factor of stroke. This study examined the importance of target blood pressure (<140/<90 mmHg) management in patients with DM. Based on the data of the 6th National Health and Nutrition Examination Survey, a total of 16,389 patients aged 18 to under 80 were assessed through regression analysis to estimate the risk of stroke through blood pressure control. The prevalence of stroke according to the presence or absence of DM was higher in the diabetic group, and a longer duration of DM indicated a higher risk of hypertension and stroke. The hazard ratio of stroke was lower in the maintenance group (0.57) of target blood pressure (<140/<90 mmHg) compared to the high blood pressure group(>140/>90 mmHg). Despite the accompanying treatment for DM and hypertension, the frequency of hypertension increased, and the prevalence of stroke increased after five years of DM. Hence, effective blood pressure management at this time is important. The risk of stroke should be reduced by continuously managing blood pressure in DM.
Keywords
Hypertension; Diabetes mellitus complication; Stroke;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459-1544. https://doi.org/10.1016/S0140-6736(16)31012-1   DOI
2 Emerging Risk Factors C, Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215-2222. https://doi.org/10.1016/S0140-6736(10)60484-9   DOI
3 Sander D, Kearney MT. Reducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives. J Neurol. 2009;256:1603-1619. https://doi.org/10.1007/s00415-009-5143-1   DOI
4 Tziomalos K, Spanou M, Bouziana SD, Papadopoulou M, Giampatzis V, Kostaki S, et al. Type 2 diabetes is associated with a worse functional outcome of ischemic stroke. World J Diabetes. 2014;5:939-944. https://doi.org/10.4239/wjd.v5.i6.939   DOI
5 Reeves MJ, Vaidya RS, Fonarow GC, Liang L, Smith EE, Matulonis R, et al. Quality of care and outcomes in patients with diabetes hospitalized with ischemic stroke: findings from Get With the Guidelines-Stroke. Stroke. 2010;41:E409-417. https://doi.org/10.1161/STROKEAHA.109.572693
6 Kruyt ND, Biessels GJ, Devries JH, Roos YB. Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol. 2010;6:145-155. https://doi.org/10.1038/nrneurol.2009.231   DOI
7 Baird TA, Parsons MW, Phan T, Butcher KS, Desmond PM, Tress BM, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003;34:2208-2214. https://doi.org/10.1161/01.STR.0000085087.41330.FF   DOI
8 Boehme AK, Esenwa C, Elkind MS. Stroke risk factors, genetics, and prevention. Circ Res. 2017;120:472-495. https://doi.org/10.1161/CIRCRESAHA.116.308398   DOI
9 Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49:e46-e99. https://doi.org/10.1161/STR.0000000000000158   DOI
10 Park TH, Ko Y, Lee SJ, Lee KB, Lee J, Han M-K, et al. Identifying target risk factors using population attributable risks of ischemic stroke by age and sex. J Stroke. 2015;17:302. https://doi.org/10.5853/jos.2015.17.3.302   DOI
11 Kim K. Relation of stroke risk factors to severity and disability after ischemic stroke. Korean J Stroke. 2012;14:136. https://doi.org/10.5853/kjs.2012.14.3.136   DOI
12 James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-520. https://doi.org/10.1001/jama.2013.284427   DOI
13 Park J. Stroke update 2009: Recent advances on stroke risk factors & primary prevention. Korean J Stroke. 2009;11:62-66.
14 Baek IK, Kim YS. The case-control study on the risk factors of stroke. J Haehwa Med. 2013;22:201-216.
15 Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et al. Primary prevention of ischemic stroke: A guideline from the American heart association/American stroke association stroke council: Cosponsored by the atherosclerotic peripheral vascular disease interdisciplinary working group; cardiovascular nursing council; clinical cardiology council; nutrition, physical activity, and metabolism council; and the quality of care and outcomes research interdisciplinary working group: The American academy of neurology affirms the value of this guideline. Stroke. 2006;37:1583-1633. https://doi.org/10.1161/01.STR.0000223048.70103.F1   DOI
16 Ha KH, Kim DJ. Current status of managing diabetes mellitus in Korea. Korean J Intern Med. 2016;31:845. https://doi.org/10.3904/kjim.2016.253   DOI
17 American Diabetes Association. Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes. 2015;33:97-111. https://doi.org/10.2337/diaclin.33.2.97   DOI
18 Alloubani A, Saleh A, Abdelhafiz I. Hypertension and diabetes mellitus as a predictive risk factors for stroke. Diabetes Metab Syndr. 2018;12:577-584. https://doi.org/10.1016/j.dsx.2018.03.009   DOI
19 Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497. https://doi.org/10.1001/jama.285.19.2486   DOI
20 Nam GE, Park HS. Perspective on diagnostic criteria for obesity and abdominal obesity in Korean adults. J Obes Metab Syndr. 2018;27:134. https://doi.org/10.7570/jomes.2018.27.3.134   DOI
21 Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:2160-2236. https://doi.org/10.1161/str.0000000000000024   DOI
22 Kaplan RC, Tirschwell DL, Longstreth WT, Jr., Manolio TA, Heckbert SR, Lefkowitz D, et al. Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly. Neurology. 2005;65:835-842. https://doi.org/10.1212/01.wnl.0000176058.09848.bb   DOI
23 Burchfiel CM, Curb JD, Rodriguez BL, Abbott RD, Chiu D, Yano K. Glucose intolerance and 22-year stroke incidence. The Honolulu Heart Program. Stroke. 1994;25:951-957. https://doi.org/10.1161/01.str.25.5.951   DOI
24 Kissela BM, Khoury J, Kleindorfer D, Woo D, Schneider A, Alwell K, et al. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care. 2005;28:355-359. https://doi.org/10.2337/diacare.28.2.355   DOI
25 Rundek T, Sacco RL. Risk factor management to prevent first stroke. Neurol Clin. 2008;26:1007-1045, ix. https://doi.org/10.1016/j.ncl.2008.09.001   DOI
26 Alva ML, Gray A, Mihaylova B, Leal J, Holman RR. The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84). Diabet Med. 2015;32:459-466. https://doi.org/10.1111/dme.12647   DOI
27 Acharya T, Huang J, Tringali S, Frei CR, Mortensen EM, Mansi IA. Statin use and the risk of kidney disease with long-term follow-up (8.4-year study). Am J Cardiol. 2016;117:647-655. https://doi.org/10.1016/j.amjcard.2015.11.031   DOI
28 Collaboration PS. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360: 1903-1913. https://doi.org/10.1016/s0140-6736(02)11911-8   DOI
29 Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HAW, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364:685-696. https://doi.org/10.1016/S0140-6736(04)16895-5   DOI